Twist Bioscience在超过200万美元的内幕交易后下跌

2026-02-20 22:21

Twist Bioscience (TWST) lost ~7% in the premarket on Friday after its Senior Vice President of Human Resources, Paula Green, sold more than $2M worth of company stock.
Green, who has served the DNA-based product for nearly a decade, disclosed the transaction in a regulatory filing on Thursday.
According to the filing, she sold more than 39.4K Twist Bioscience (TWST) shares on Tuesday for an average price of $52.40 apiece. The transaction, worth nearly $2.1M, has lowered her stake in Twist (TWST) by 24% to roughly 126.0K shares.
The sale comes after shares of the San Francisco, California-based biotech climbed more than 65% this year, including nearly 14% on Feb. 2 in reaction to a guidance hike issued with the company’s Q1 FY26 results.

More on Twist Bioscience